The Uromigos Episode 80: Results for Darolutamide in Non-Metastatic CRPC—The Aramis Trial

By The Uromigos - February 13, 2021

Dr. Neal Shore presents the impressive updates for the results of the Aramis trial, examining Darolutamide for patients with non-metastatic castration-resistant prostate cancer.

Post Tags:Uromigos-Prostate Cancer
Did you like this article?